Literatur
Woyach JA et al. N Engl J Med. 2018;379(26):2517-28
Shanafelt TD et al. N Engl J Med. 2019;381(5):432-43
Al-Sawaf O et al. J Clin Oncol. 2021;39(36):4049-60
Eichhorst B et al. N Engl J Med. 2023;388(19):1739-54
Benintende G et al. Front Oncol. 2023;13:1112616
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hiller, E. Steuerung der CLL-Therapie mithilfe der messbaren Resterkrankung. InFo Hämatol Onkol 27, 21–22 (2024). https://doi.org/10.1007/s15004-024-0501-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-024-0501-9